Support By : Li-lab
PATHWAY_NAME | REACTOME_ID | KEGG_ID | DRUG_NAME | PUBCHEM_CID | Datasource |
---|---|---|---|---|---|
Pathogenic Escherichia coli infection | R-HSA-9609646 | map05130 | allantoin | 204 | drug-path |
Gap junction | R-HSA-190861 | map04540 | allantoin | 204 | drug-path |
Leukocyte transendothelial migration | R-HSA-8950732 | map04670 | todralazine | 6914273 | drug-path |
Olfactory transduction | R-HSA-9751605 | map04740 | todralazine | 6914273 | drug-path |
Neuroactive ligand-receptor interaction | R-HSA-5632681 | map04080 | todralazine | 6914273 | drug-path |
Systemic lupus erythematosus | R-HSA-977105 | map05322 | todralazine | 6914273 | drug-path |
VEGF signaling pathway | R-HSA-194138 | map04370 | todralazine | 6914273 | drug-path |
Bladder cancer | R-HSA-9700206 | map05219 | todralazine | 6914273 | drug-path |
Regulation of actin cytoskeleton | R-HSA-392751 | map04810 | todralazine | 6914273 | drug-path |
Melanogenesis | R-HSA-5662702 | map04916 | dexpanthenol | 131204 | drug-path |
Type II diabetes mellitus | R-HSA-2127377 | map04930 | dexpanthenol | 131204 | drug-path |
Graft-versus-host disease | R-HSA-1643685 | map05332 | dexpanthenol | 131204 | drug-path |
Hematopoietic cell lineage | R-HSA-173752 | map04640 | dexpanthenol | 131204 | drug-path |
Autoimmune thyroid disease | R-HSA-1643685 | map05320 | dexpanthenol | 131204 | drug-path |
Antigen processing and presentation | R-HSA-1236975 | map04612 | dexpanthenol | 131204 | drug-path |
Cell adhesion molecules (CAMs) | R-HSA-1031690 | 0 | dexpanthenol | 131204 | drug-path |
Asthma | R-HSA-444620 | map05310 | dexpanthenol | 131204 | drug-path |
RNA polymerase | R-HSA-73864 | map03020 | dexpanthenol | 131204 | drug-path |
Allograft rejection | R-HSA-9679028 | map05330 | dexpanthenol | 131204 | drug-path |
Type I diabetes mellitus | R-HSA-5683209 | map04940 | dexpanthenol | 131204 | drug-path |